Work

SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines

Year: 2018

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2018.07.004

Authors: Chung-Pu Wu, Megumi Murakami, Sung-Han Hsiao, Te-Chun Liu, Ni Yeh, Yan-Qing Li, Tai-Ho Hung, Yu-Shan Wu, Suresh. V. Ambudkar

Institutions: Chang Gung University, Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, National Institutes of Health, National Cancer Institute, Center for Cancer Research, Tunghai University

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Center for Cancer Research, Ministry of Science and Technology, Taiwan, Taichung Veterans General Hospital, National Institutes of Health, National Cancer Institute

Awards: Investigation on the Role and Regulation of Mammalian Target of Rapamycin (mTOR) in Placental Autophagy Induced by Oxygen-Glucose Deprivation, Developing Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy, G7375548807, Investigation of Drug-Drug Interactions Mediated by the Atp-Binding Cassette Drug Transporters Abcb1 and Abcg2, G8104272235, G832022840, G9000273969

OpenAlex ID: W2861210401

FWCI: 0.842

Cites: 76

Cited by: 23

Related to: 10